Brains and superior algorithm, for the benefits of patients
Genomic privacy protection guaranteed
Highly accurate and reliable NGS data analysis
Standardisation of the Clinical NGS Dry Lab for higher quality and accuracy of routine NGS-based clinical diagnostics.
Integrated bioinformatic analysis, quality assurance, visualisation and banking of patient NGS data.
Superior algorithm with specific analysis pipelines for each combination of sample type, gene panel, DNA amplification or capture kit and sequencing platform.
Fully validated, automated analysis pipelines for both commercial and proprietary custom panels of genes on any NGS platform. CE/IVD marked analysis pipelines when appropriate.
A proven methodology to optimise, validate the analytical performance and put in production robust bioinformatic pipelines for usage in routine diagnostics.
Privately hosted IT Infrastructure. Commitment to constantly provide processing power and storage capacity under a strict Service Level Agreement.
A single efficient workflow covering all activities of the Clinical NGS Dry Lab through the use of dropGen, a secured web Application provided in SaaS mode (Software as a Service).
Shortly after receiving ISO 13485 accreditation, Sophia Genetics has become the first European company to obtain a CE-IVD mark for the clinical use of an Next Generation Sequencing (NGS) bioinformatic pipeline for routine genetic testing. This quality assurance certification represents an important step in raising the standards of routine genetic testing and clinical diagnosis, and brings Sophia Genetics’ world-leading Data Driven Medicine platform to a wider market.see more